New guidelines related to pulmonary embolism could provide a boost for Boston Scientific (NYSE: BSX) and Stryker (NYSE: SYK), among others. Yesterday, the American Heart Association (AHA) and American College of Cardiology (ACC) joint committee updated its guidelines for pulmonary embolism (PE). This marks the first update since the AHA last … [Read more...] about AHA, ACC issue guidelines for pulmonary embolism that affect Boston Scientific, Stryker
Technologies & Devices
Catheter Precision to sell atherectomy catheter assets, focus on electrophysiology
Catheter Precision (NYSE:VTAK) announced today that it agreed to divest its atherectomy catheter technologies to an unnamed strategic acquirer. The company said it conducted a comprehensive portfolio review and determined that monetizing its non-core assets enhances its capital efficiency and sharpens focus on its high-growth electrophysiology … [Read more...] about Catheter Precision to sell atherectomy catheter assets, focus on electrophysiology
Simpson Interventions closes Series C, rebrands to Elumn8 Medical
Simpson Interventions announced that it closed its Series C financing and rebranded to Elumn8 Medical. The Campbell, California–based company plans to use the undisclosed amount of proceeds raised in the Series C to support the continued development of its Acolyte image-guided crossing and re-entry catheter system. Acolyte aims to treat … [Read more...] about Simpson Interventions closes Series C, rebrands to Elumn8 Medical
St. Jude Medical founder Manny Villafaña looks to take Medical 21 venture public
Medical 21, the latest venture for a major figure in medtech, has filed a Form S-1 with the U.S. SEC to initiate the process of an initial public offering (IPO). Manny Villafaña founded Medical 21 in 2016, marking his latest venture after leading multiple big names in medtech. Villafaña founded, among others, CPI, which as acquired by Guidant … [Read more...] about St. Jude Medical founder Manny Villafaña looks to take Medical 21 venture public
InVera Medical wins European approval for vein infusion device
InVera Medical announced recently that it picked up European approval for its minimally invasive device for delivering vein treatments. The Galway, Ireland-based company designed its device to help deliver treatment more effectively to diseased leg veins, including varicose veins. CE mark approval enables the marketing of the InVera Infusion … [Read more...] about InVera Medical wins European approval for vein infusion device
Valcare announces first transseptal implantation of Amend annuloplasty system in U.S.
Valcare Medical announced the first successful U.S. transseptal implantation of its Amend transcatheter mitral valve repair annuloplasty system. The milestone implantation was a part of an ongoing early feasibility study, according to the company’s statement released today. “Annuloplasty has served as the foundation of more than 95% of surgical … [Read more...] about Valcare announces first transseptal implantation of Amend annuloplasty system in U.S.
The biggest cardiac tech news out of the 2026 AF Symposium
Last week, the leading developers of treatments for atrial fibrillation (AFib) convened in Boston for the 2026 AF Symposium. At the event, the makers of technologies like pulsed field ablation (PFA) systems, left atrial appendage (LAA) devices, heart access catheters and more offered insights into how their therapies contribute to the treatment … [Read more...] about The biggest cardiac tech news out of the 2026 AF Symposium
Boston Scientific Farapulse PFA outperforms thermal ablation in study
Boston Scientific (NYSE:BSX) has announced new data backing its Farapulse pulsed field ablation (PFA) platform for treating AFib. Farapulse, a nonthermal treatment, uses electric fields to selectively ablate heart tissue. It's one of the leading PFA systems in a market that includes Medtronic, Johnson & Johnson … [Read more...] about Boston Scientific Farapulse PFA outperforms thermal ablation in study
Argá Medtech data supports single-catheter PFA system
Argá Medtech today announced positive findings from a first-in-human study of its Coherent Sine-Burst Electroporation (CSE) system. Lausanne, Switzerland–based Argá’s BURST-AF study evaluates the CSE pulsed field ablation (PFA) system. It looks at the treatment of paroxysmal and persistent AFib. It demonstrated 94% overall lesion durability, … [Read more...] about Argá Medtech data supports single-catheter PFA system
Atraverse reports positive data for Hotwire transseptal access system
Atraverse Medical today announced new clinical and preclinical data supporting its Hotwire transseptal access system. Hotwire is a novel radiofrequency guidewire left-heart access device. It enables zero-exchange left-heart access while acting as a rail for catheter-based therapy systems. Steven Mickelsen, a pioneer in the pulsed field ablation … [Read more...] about Atraverse reports positive data for Hotwire transseptal access system
